Miocardiopatías III. Miocardiopatía restrictiva. Displasia arritmogénica del ventrículo derecho. Miocardiopatía no compactada

  1. Ortiz Bautista, C.
  2. Salguero Bodes, R.
  3. Delgado Jiménez, J.F.
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2017

Issue Title: Enfermedades cardiológicas (IX) Miocardiopatías

Series: 12

Issue: 43

Pages: 2573-2584

Type: Article

DOI: HTTPS://DOI.ORG/10.1016/J.MED.2017.10.013 DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

Abstract Restrictive cardiomyopathy (RCM) is a rare entity characterised by increased left ventricular filling with normal systolic function and left ventricular thickness. These findings can appear in association with various inflammatory, infiltrative or deposition (secondary) diseases. However, recent results of molecular genetics research studies have demonstrated that a significant amount of RCM cases with no associated systemic disease are caused by sarcomeric gene mutations, previously associated with hypertrophic cardiomyopathy, dilated cardiomyopathy and non-compaction (primary) cardiomyopathy. In general, patients develop serious symptoms of heart failure over a short period of time, and most die within a few years after diagnosis unless they undergo heart transplantation. The objective of this update is to review the different clinical entities that present like RCM. We shall also review other cardiomyopathies that are not classified into the three classical types

Bibliographic References

  • Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29(2):270-6.
  • Mogensen J, Arbustini E. Restrictive cardiomyopathy. Curr Opin Cardiol. 2009;24(3):214-20.
  • Sen-Chowdhry S, Syrris P, McKenna WJ. Genetics of restrictive cardiomyopathy. Heart Fail Clin. 2010;6(2):179-86.
  • Gallego-Delgado M, Delgado JF, Brossa-Loidi V, Palomo J, Marzoa-Rivas R, Pérez-Villa F. Idiopathic restrictive cardiomyopathy is primarily a genetic disease. J Am Coll Cardiol. 2016;67(25):3021-3.
  • Ammash NM, Seward JB, Bailey KR, Edwards WD, Tajik AJ. Clinical profile and outcome of idiopathic restrictive cardiomyopathy. Circulation. 2000;101(21):2490-6.
  • Grimaldi A, Mocumbi AO, Freers J, Lachaud M, Mirabel M, Ferreira B. Tropical endomyocardial fibrosis: natural history, cha-llenges, and perspectives. Circulation. 2016;133(24):2503-15.
  • Beaton A, Mocumbi AO. Diagnosis and management of endomyocardial fibrosis. Cardiol Clin. 2017;35(1):87-98.
  • Birnie DH, Kandolin R, Nery PB, Kupari M. Cardiac manifestations of sarcoidosis: diagnosis and management. Eur Heart J. En prensa 2016.
  • Birnie DH, Nery PB, Ha AC, Beanlands RS. Cardiac Sarcoidosis. J Am Coll Cardiol. 2016;68(4):411-21.
  • Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur J Heart Fail. 2016;18(8):891-975.
  • Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet. 2016;387(10038):2641-54.
  • Rapezzi C, Lorenzini M, Longhi S, Milandri A, Gagliardi C, Bartolomei I. Cardiac amyloidosis: the great pretender. Heart Fail Rev. 2015;20(2):117-24.
  • Falk RH, Alexander KM, Liao R, Dorbala S. AL (light chain) cardiac amyloidosis. A review of diagnosis and therapy. J Am Coll Cardiol. 2016;68(12):1323-41.
  • Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloido-sis. J Clin Oncol. 2004;22:3751-57.
  • Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Chris-takis J. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet. 2003;33:21-2.
  • Gulati V, Harikrishnan P, Palaniswamy C, Aronow WS, Jain D, Frishman WH. Cardiac involvement in hemochromatosis. Cardiol Rev. 2014;22(2): 56-68.
  • Olson LJ, Edwards WD, Holmes DR Jr, Miller FA Jr, Nordstrom LA, Baldus WP. Endomyocardial biopsy in hemochromatosis: clini-copathologic correlates in six cases. J Am Coll Cardiol. 1989;13:116-20.
  • Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011;54:328.
  • Nagueh SF. Anderson-Fabry disease and other lysosomal storage disorders. Circulation. 2014;130(13):1081-90.
  • Corrado D, Link MS, Calkins H. Arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2017;376(15):1489-90.
  • Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy: dysplasia, dystrophy, or myocarditis? Circulation.1996;94:983-91.
  • McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet. 2000;355:2119-24.
  • Corrado D, Zorzi A, Cerrone M, Rigato I, Mongillo M, Bauce B. Relationship between arrhythmogenic right ventricular car-diomyopathy and Brugada syndrome: new insights from molecular biology and clinical implications. Circ Arrhythm Electrophysiol. 2016;9(4):e003631.
  • Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA. Diagnosis of arrhythmogenic right ventricular car-diomyopathy/dysplasia: proposed modification of the Task Force Criteria. Circulation. 2010;121(13):1533-41.
  • Groeneweg JA, Bhonsale A, James CA, te Riele AS, Dooijes D, Tichnell C. Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia/cardiomyopathy patients and family members. Circ Cardiovasc Genet. 2015;8:437-46.
  • Towbin JA, Lorts A, Jefferies JL. Left ventricular non compaction cardiomyopathy. Lancet. 2015;386(9995):813-25.
  • Bhatia NL, Tajik AJ, Wilansky S, Steidley DE, Mookadam F. Isolated noncompaction of the left ventricular myocardium in adults: a systematic overview. J Card Fail. 2011;17:771-8.
  • Petersen SE, Selvanayagam JB, Wiesmann F, Robson MD, Francis JM, Anderson RH. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2005;46:101-05.
  • Jacquier A, Thuny F, Jop B, Giorgi R, Cohen F, Gaubert JY. Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non compaction. Eur Heart J. 2010;31:1098-104.
Data source: Dialnet